B-cell childhood acute lymphoblastic leukemia
MONDO:0000872An acute B-lymphoblastic leukemia occurring in children.
Also known as: B acute lymphoblastic leukaemia, B acute lymphoblastic leukemia, B cell childhood ALL, B cell childhood acute lymphoblastic leukaemia, B cell childhood acute lymphoblastic leukemia, B cell childhood acute lymphocytic leukaemia, B cell childhood acute lymphocytic leukemia, B cell paediatric ALL
3374 clinical trials for this condition and its sub-types, 37 tagged with B-cell childhood acute lymphoblastic leukemia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Can a new combo drug tame childhood leukemia that Won't quit?
Disease control Not yet recruitingThis trial is investigating whether a new drug called sonrotoclax, when combined with other anti-cancer medicines, is safe and effective for children and adolescents with acute myeloid leukemia (AML) or B-cell acute lymphoblastic leukemia (ALL) that has returned or not responded …
Phase 1/2 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New combo aims to wipe out hidden leukemia cells
Disease control Not yet recruitingThis study tests whether adding a new drug called revumenib to the usual treatment (blinatumomab plus chemotherapy) can better clear leftover leukemia cells in people with a specific genetic type of B-cell acute lymphoblastic leukemia (ALL) or mixed-lineage leukemia. About 90 adu…
Phase 2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New CAR-T therapy aims to outsmart resistant blood cancers
Disease control Not yet recruitingThis early study tests a new type of immune cell therapy called Sup19 CAR-T in 9 adults with B-cell acute lymphoblastic leukemia or lymphoma. It is for patients whose cancer stopped responding to previous CD19-targeted treatments or has low levels of CD19. The main goal is to che…
Phase 1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Experimental 'Off-the-Shelf' NK cells aim to fight childhood leukemia
Disease control Not yet recruitingThis early-phase trial tests JY509, a universal natural killer (NK) cell therapy, in 18 children with relapsed or refractory B-cell acute lymphoblastic leukemia. The cells are given as a single injection to see if they are safe and can help control the disease. The study uses a d…
Early phase 1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Off-the-Shelf cell therapy takes aim at tough blood cancers
Disease control Not yet recruitingThis early study tests a new treatment for people with B-cell blood cancers that have come back or not responded to standard therapy. The treatment uses donor immune cells (CAR-T cells) designed to find and attack cancer cells. The main goal is to check if it's safe, with a small…
Phase 1 • Sponsor: YANRU WANG • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC